2.95

2.96% -0.09

After Hours: 3.01 0.06 +2.03%

Fortress Biotech Inc (FBIO)

Overview News Price History Option Chain Financials Why FBIO Down? Discussions Forecast Stock Split

Fortress Biotech Inc stock is traded at $2.95, with a volume of 410.30K. It is down -2.96% in the last 24 hours and up +11.32% over the past month. Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.

Previous Close:

$3.04

Open:

$3.03

24h Volume:

410.30K

Relative Volume:

0.90

Market Cap:

$98.00M

Revenue:

$66.16M

Net Income/Loss:

$128.94M

P/E Ratio:

0.927

EPS:

3.1823

Net Cash Flow:

$152.08M

1W Performance:

+0.00%

1M Performance:

+11.32%

6M Performance:

-29.93%

1Y Performance:

+56.91%

1-Day Range:

$2.935

$3.075

1-Week Range:

$2.85

$3.20

52-Week Range:

$1.77

$4.53

Fortress Biotech Inc Stock (FBIO) Company Profile

Name

Fortress Biotech Inc

Sector

Healthcare (1100)

Industry

Biotechnology (615)

Phone

781-652-4500

Address

1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY

Employee

Twitter

@fortressbio

Next Earnings Date

2026-08-13

Latest SEC Filings

FBIO's Discussions on Twitter

Compare FBIO vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
FBIO Fortress Biotech Inc	2.95	101.65M	66.16M	128.94M	152.08M	3.1823
VRTX Vertex Pharmaceuticals Inc	529.59	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	649.81	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	916.80	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	313.04	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.99	39.82B	742.00K	-1.37B	-1.07B	-7.0731

Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-15-24	Resumed	ROTH MKM	Buy
Aug-04-22	Initiated	Ladenburg Thalmann	Buy
Oct-02-20	Initiated	The Benchmark Company	Buy
Dec-18-19	Initiated	B. Riley FBR	Buy
Feb-28-18	Initiated	B. Riley FBR, Inc.	Buy
Jul-11-17	Initiated	Rodman & Renshaw	Buy
Mar-22-17	Initiated	JMP Securities	Mkt Outperform
Oct-03-16	Initiated	ROTH Capital	Buy

View All

Fortress Biotech Inc Stock (FBIO) Latest News

Jun 26, 2026

Fortress Biotech, Inc. Actuals & Estimates (NASDAQ:FBIO) - TradingView

Jun 26, 2026

Trading the Move, Not the Narrative: (FBIOP) Edition - Stock Traders Daily

Jun 26, 2026

Jun 25, 2026

Fortress Biotech, Inc.9.375% Series A Cumulative Redeemable Perpetual Preferred Stock - TradingView

Jun 25, 2026

FBIO Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Price to sales forward of Fortress Biotech, Inc. – NASDAQ:FBIO - TradingView

Jun 25, 2026

Journey Medical (DERM) Stock Draws Fresh Price Target Split After Fortress Valuation Changes - Yahoo Finance

Jun 25, 2026

Jun 24, 2026

Fortress Biotech (NASDAQ: FBIO) CFO receives 400,000 RSU award - Stock Titan

Jun 24, 2026

Form 4 Fortress Biotech Inc For: 24 June By Investing.com - Investing.com South Africa

Jun 24, 2026

Enterprise value to revenue forward of Fortress Biotech, Inc. – NASDAQ:FBIO - TradingView

Jun 24, 2026